Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$94.73 - $105.13 $689,350 - $765,031
-7,277 Reduced 4.84%
142,929 $14.6 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $271,268 - $307,596
-2,932 Reduced 1.91%
150,206 $15.2 Million
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $398,629 - $462,286
-4,981 Reduced 3.15%
153,138 $14.1 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $11.9 Million - $14.6 Million
158,119 New
158,119 $14.3 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $13.2 Million - $15.5 Million
177,453 New
177,453 $13.5 Million
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $378,041 - $440,156
-4,695 Reduced 2.53%
180,548 $15.3 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $14.8 Million - $16.8 Million
185,243 New
185,243 $16.3 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $18.2 Million - $20.1 Million
-227,872 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
$81.78 - $95.14 $3.01 Million - $3.5 Million
-36,809 Reduced 13.91%
227,872 $18.6 Million
Q2 2021

Aug 12, 2021

SELL
$85.24 - $94.15 $2.2 Million - $2.43 Million
-25,786 Reduced 8.88%
264,681 $24.1 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $6.81 Million - $8.03 Million
-81,537 Reduced 21.92%
290,467 $24.8 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $15.7 Million - $19 Million
-201,023 Reduced 35.08%
372,004 $35.1 Million
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $1.69 Million - $1.87 Million
20,539 Added 3.72%
573,027 $49.8 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $1.99 Million - $2.24 Million
24,596 Added 4.66%
552,488 $48.3 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $445,291 - $623,862
6,301 Added 1.21%
527,892 $43.5 Million
Q4 2019

Feb 11, 2020

SELL
$84.35 - $95.37 $29,269 - $33,093
-347 Reduced 0.07%
521,591 $49.4 Million
Q3 2019

Nov 12, 2019

BUY
$85.54 - $94.26 $1.91 Million - $2.1 Million
22,282 Added 4.46%
521,938 $45.4 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $2.18 Million - $2.69 Million
28,969 Added 6.15%
499,656 $0
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $6.55 Million - $7.5 Million
87,024 Added 22.68%
470,687 $0
Q4 2018

Feb 15, 2019

BUY
$73.66 - $82.02 $23.1 Million - $25.7 Million
312,989 Added 442.86%
383,663 $29.5 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $154,631 - $178,863
-2,310 Reduced 3.17%
70,674 $0
Q2 2018

Aug 08, 2018

BUY
$64.91 - $73.36 $1.67 Million - $1.89 Million
25,741 Added 54.49%
72,984 $0
Q1 2018

May 16, 2018

SELL
$70.39 - $84.15 $192,305 - $229,897
-2,732 Reduced 5.47%
47,243 $0
Q4 2017

Feb 15, 2018

BUY
$72.33 - $77.64 $216 - $232
3 Added 0.01%
49,975 $0
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $3.7 Million - $3.86 Million
49,972
49,972 $0

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.